The UK has joined new global network of health regulators focused on the safe, effective use of artificial intelligence (AI) in healthcare.

The Medicines and Healthcare products Regulatory Agency (MHRA) will work with regulators around the world to share early warnings on safety, monitor how AI tools perform in practice, and shape international standards.

The MHRA has already updated guidance and begun reforming medical device safety regulations, and continues to adapt them for fast-developing areas such as adaptive and generative AI. The agency is also working with researchers, National Institute for Health and Care Excellence (NICE) and the NHS to strengthen real-world evidence on how these tools perform in practice.

With the UK becoming the first country to join, a signing ceremony took place at Westminster with Science Minister Lord Vallance, MHRA Chief Executive Lawrence Tallon and Dr Ricardo Baptista Leite, CEO of HealthAI.

Health and Social Care Secretary Wes Streeting said: “I’m delighted that the UK has been invited to become a Pioneer Country in HealthAI’s Global Regulatory Network.

“This recognition underscores our commitment to being at the forefront of responsible AI innovation in healthcare. As we implement our 10 Year Health Plan, cutting-edge technology will be crucial to transforming patient care and NHS efficiency.

“Working with international partners through this network will ensure we harness AI’s incredible potential, while maintaining the highest standards of safety and ethics.”

Science and Tech Secretary Peter Kyle said: “The UK is leading the way in making sure AI delivers real-world benefits – from better care for patients to new opportunities for growth.”

“By shaping global standards and breaking down unnecessary regulatory barriers at home, we’re helping innovators to get trusted tools into the NHS faster, improving treatments for patients while growing our economy in support of our Plan for Change.”